Summary of Conference Call Company Overview - The discussion revolves around Oscar Health, a health insurance company, focusing on its performance in 2025 and expectations for 2026 [2][5]. Key Points 2025 Performance and 2026 Outlook - 2025 was a challenging year for Oscar and the broader marketplace due to misestimations of market morbidity, leading to losses [2]. - For 2026, Oscar has prepared for market shrinkage, expecting a decrease in membership from 3.4 million to approximately 3 million due to passively enrolled members not making payments [3][4]. - The company has priced for risks associated with market morbidity, anticipating a shrinkage in the 20%-30% range, but now expects it to be closer to 20% [3][4]. Membership and Retention - Oscar ended the open enrollment period with about 3.4 million members and expects to start the second quarter with around 3 million [2][3]. - The company has seen strong retention rates compared to peers, attributed to proactive measures taken over the past two years, including aggressive distribution engagement and strong plan designs [7][9]. Risk Management and Profitability - Oscar has implemented tools to assess risk scores for new members, which generally tend to be younger and healthier, leading to better profitability profiles in year two compared to year one [20][26]. - The company anticipates that the risk adjustment will be higher in the first half of the year, contributing to a 20% of premium revenue, compared to 18.5% the previous year [30]. Market Dynamics and Regulatory Environment - The marketplace is expected to shrink from approximately 24 million to 20 million members, with Oscar's peers experiencing greater attrition [6]. - Oscar has factored in potential impacts from regulatory changes and integrity measures introduced by CMS, which are expected to be implemented mid-year [34][43]. Metal Tier Changes - The company has shifted its membership mix from predominantly Silver plans to a more balanced distribution among Bronze, Silver, and Gold plans, with a significant increase in Gold plan enrollments [61][66]. - Historical performance metrics may not apply due to this shift in membership dynamics [64]. Individual Coverage Health Reimbursement Arrangement (ICHRA) - ICHRA allows employees to choose their health plans using employer-provided funds, promoting individualization and choice in healthcare [70][72]. - The tax treatment for ICHRA subsidies is favorable for both employees and employers, potentially leading to increased adoption in the future [74]. Financial Preparedness - Oscar has raised $400 million to prepare for growth and has established a $475 million revolver with top-tier banks, ensuring sufficient capital for expansion [95][96]. - The company utilizes quota share reinsurance, which covers approximately 55% of the capital required based on premiums, enhancing financial stability [97]. Cost Trends - The company experienced a per-member decline in medical costs in the latter part of the previous year, but anticipates a 12% trend in medical expenses for 2026 due to market morbidity and other factors [99][104]. Additional Insights - Oscar's proactive approach to risk management and market engagement positions it favorably compared to competitors, with a focus on maintaining a healthy member base and adapting to regulatory changes [7][34][43].

Group 1 - The third quarter results were impacted by the Wakely data, which raises questions about future data weighting for the remainder of the year [1] - The company mentioned that FTR and other program integrity measures were not included in the results, suggesting potential positive outcomes as these members tend to carry higher value [1]

Financial Data and Key Metrics Changes - The company reported an adjusted per share loss of $0.16 for Q2 2025, which was below the financial goals set at the beginning of the year [6][31] - Total premium and service revenue for Q2 2025 was $42.5 billion, reflecting challenges in the marketplace and Medicaid segments [31][39] - The adjusted diluted EPS forecast for the full year 2025 is now approximately $1.75, significantly down from the previous guidance of $7.25 [22][38] Business Line Data and Key Metrics Changes - Marketplace membership reached 5.9 million, generating over $10 billion in commercial premium and service revenue, but faced a $1.2 billion pretax drag due to risk adjustment transfer revenue shortfalls [7][8] - The Medicaid health benefits ratio (HBR) was reported at 94.9%, driven by increased medical costs in behavioral health, home health, and high-cost drugs [14][18] - Medicare Advantage is on track for breakeven in 2027, with PDP membership stable at 7.8 million and showing improved performance [20][21] Market Data and Key Metrics Changes - The company anticipates a $2.4 billion headwind to 2025 pretax earnings due to a shift in marketplace risk pool, with morbidity increasing by 16% to 17% in some states [10][22] - Medicaid rate adjustments are expected to be around 5% for 2025, an increase from the previous expectation of 4% [18][22] - The overall market is expected to contract further, with membership projected to decrease to 5.4 million by the end of 2025 [67] Company Strategy and Development Direction - The company is focused on restoring profitability in the Marketplace business by repricing for 2026 to account for morbidity shifts and enhancing operational efficiency [12][26] - In Medicaid, the strategy includes advocating for rate adjustments and managing costs through improved provider networks and fraud prevention [15][17] - The company aims to leverage its size and scale to create transparency in the market and ensure stability in pricing and risk adjustment processes [75] Management's Comments on Operating Environment and Future Outlook - Management expressed disappointment with Q2 performance but emphasized a unified focus on restoring earnings trajectory and improving performance across the portfolio [6][31] - The company is actively engaging with state partners to address Medicaid cost trends and is optimistic about securing sufficient rates to support sustainable margins [19][60] - Future earnings potential is seen in the long-term stability of Medicaid, Medicare, and the individual marketplace, despite current challenges [39][30] Other Important Information - The company has filed 2026 pricing in 17 states and expects to submit additional filings soon, aiming for a comprehensive repricing strategy [12][33] - Cash flow from operations for Q2 was $1.8 billion, with unregulated cash on hand at $234 million [37] - The company does not anticipate further share buybacks in 2025 but remains open to opportunistic actions based on market conditions [37] Q&A Session Summary Question: Capital position and potential needs for additional capital - The company plans to inject a net $300 million into subsidiaries in the second half of the year, with a renewed $4 billion credit facility available [42][44] Question: Risk adjustment impacts and repricing strategy - Management acknowledged the significant morbidity shift affecting the marketplace and is adjusting expectations for 2026 pricing accordingly, aiming for profitability [48][51] Question: Medicaid margin improvement expectations - Management expects to deliver margin improvement in Medicaid, focusing on specific states that contributed to Q2 underperformance [56][59] Question: Market size and membership trends - The company anticipates further market contraction and membership attrition, projecting a decrease to 5.4 million members by year-end [67][68] Question: Strategy for risk adjustment payables - The company is considering product and benefit structure adjustments to optimize for sustainable margins while addressing risk adjustment dynamics [71][75]